Role of bare-metal stents for left main coronary artery disease in the era of drug-eluting stents - Which coronary stent should be used for left main trunk disease - BMS or DES (BMS-side)

Circulation Journal

Volumn 75, Issue 5, 2011, Pages 1243-1249

  Kaneko, Hironori ^a   Kijima, Mikihiro ^a  

^a HOSHI GENERAL HOSPITAL   (Japan)

Author keywords

Coronary artery disease; Percutaneous coronary intervention; Prognosis; Revascularization; Stents

Indexed keywords

RAPAMYCIN;

ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; HUMAN; INTERMETHOD COMPARISON; LEFT CORONARY ARTERY; RESTENOSIS; RISK FACTOR; STENT THROMBOSIS; TREATMENT FAILURE; TREATMENT RESPONSE;

CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; METALS; STENTS; TREATMENT OUTCOME;

EID: 79955692577     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0234     Document Type: Article

References (49)

1. Silvestri M, Barragan P, Sainsous J, Bayet G, Simeoni JB, Roquebert PO, et al. Unprotected left main coronary artery stenting: Immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol 2000; 35: 1543-1550.
2. Black A, Cortina R, Bossi I, Choussat R, Fajadet J, Marco J. Unprotected left main coronary artery stenting: Correlates of midterm survival and impact of patient selection. J Am Coll Cardiol 2001; 37: 832-838.
3. Park SJ, Hong MK, Lee CW, Kim JJ, Song JK, Kang DH, et al. Elective stenting of unprotected left main coronary artery stenosis: Effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol 2001; 38: 1054-1060.
4. Tan WA, Tamai H, Park SJ, Plokker HW, Nobuyoshi M, Suzuki T, et al. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation 2001; 104: 1609-1614.
5. Park SJ, Park SW, Hong MK, Lee CW, Lee JH, Kim JJ, et al. Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am J Cardiol 2003; 91: 12-16.
6. Lee BK, Hong MK, Lee CW, Choi BR, Kim MJ, Park KH, et al. Five-year outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Int J Cardiol 2007; 115: 208-213.
7. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008; 358: 1781-1792.
8. Park DW, Seung KB, Kim YH, Lee JY, Kim WJ, Kang SJ, et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol 2010; 56: 117-124.
9. Brueren BR, Ernst JM, Suttorp MJ, ten Berg JM, Rensing BJ, Mast EG, et al. Long term follow up after elective percutaneous coronary intervention for unprotected non-bifurcational left main stenosis: Is it time to change the guidelines? Heart 2003; 89: 1336-1339.
10. Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano M, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 2005; 111: 791-795.
11. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006; 47: 864-870.
12. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: A single-center experience. Circulation 2006; 113: 2542-2547.
13. Katsuki T. What is the best way to treat left main coronary artery disease? Circ J 2009; 73: 626-627.
14. Chieffo A, Magni V, Latib A, Maisano F, Ielasi A, Montorfano M, et al. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience. JACC Cardiovasc Interv 2010; 3: 595-601.
15. Takagi H, Umemoto T. Drug-eluting stents vs bypass surgery for unprotected left main disease. Circ J 2010; 74: 2244.
16. Nishimi M, Tashiro T. Off-pump coronary artery bypass vs percutaneous coronary intervention: Therapeutic strategies for 3-vessel coronary artery disease: OPCAB vs PCI (OPCAB-Side). Circ J 2010; 74: 2750-2757.
17. Erglis A, Narbute I, Kumsars I, Jegere S, Mintale I, Zakke I, et al. A randomized comparison of paclitaxel-eluting stents versus baremetal stents for treatment of unprotected left main coronary artery stenosis. J Am Coll Cardiol 2007; 50: 491-497.
18. Han Y, Wang S, Jing Q, Li Y, Liu H, Ma Y, et al. Comparison of long-term efficacy of the paclitaxel-eluting stent versus the baremetal stent for treatment of unprotected left main coronary artery disease. Am J Cardiol 2009; 103: 194-198.
19. Palmerini T, Barlocco F, Santarelli A, Bacchi-Reggiani L, Savini C, Baldini E, et al. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). Eur Heart J 2007; 28: 2714-2719.
20. Schrale RG, van Gaal W, Channon KM, Forfar JC, Ormerod OJ, Banning AP. Long-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery disease. Int J Cardiol 2008; 130: 185-189.
21. Kim YH, Park DW, Lee SW, Yun SC, Lee CW, Hong MK, et al. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents. Circulation 2009; 120: 400-407.
22. Tamburino C, Di Salvo ME, Capodanno D, Palmerini T, Sheiban I, Margheri M, et al. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes. Am J Cardiol 2009; 103: 187-193.
23. Tamburino C, Di Salvo ME, Capodanno D, Marzocchi A, Sheiban I, Margheri M, et al. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. Eur Heart J 2009; 30: 1171-1179.
24. Gao RL, Xu B, Chen JL, Yang YJ, Qiao SB, Li JJ, et al. Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: Comparison with baremetal stent implantation. Am Heart J 2008; 155: 553-561.
25. Pandya SB, Kim YH, Meyers SN, Davidson CJ, Flaherty JD, Park DW, et al. Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis. JACC Cardiovasc Interv 2010; 3: 602-611.
26. Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia-Garcia HM, Polad J, Tsuchida K, et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: An integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries. J Am Coll Cardiol 2006; 47: 1530-1537.
27. Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Ueda H, Kawai K, et al. Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: Insights from the j-Cypher registry. Circulation 2009; 120: 1866-1874.
28. Di Mario C, Karvouni E. The bigger, the better: True also for instent restenosis? Eur Heart J 2000; 21: 710-711.
29. Kasaoka S, Tobis JM, Akiyama T, Reimers B, Di Mario C, Wong ND, et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol 1998; 32: 1630-1635.
30. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-1249.
31. Costa RA, Mintz GS, Carlier SG, Lansky AJ, Moussa I, Fujii K, et al. Bifurcation coronary lesions treated with the "crush" technique: An intravascular ultrasound analysis. J Am Coll Cardiol 2005; 46: 599-605.
32. Kim YH, Park SW, Hong MK, Park DW, Park KM, Lee BK, et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol 2006; 97: 1597-1601.
33. Palmerini T, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, et al. Impact of bifurcation technique on 2-year clinical outcomes in 773 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents. Circ Cardiovasc Interv 2008; 1: 185-192.
34. Palmerini T, Sangiorgi D, Marzocchi A, Tamburino C, Sheiban I, Margheri M, et al. Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: Results of the survey from the Italian Society of Invasive Cardiology. Eur Heart J 2009; 30: 2087-2094.
35. Tanaka N, Terashima M, Kinoshita Y, Kimura M, Nasu K, Ehara M, et al. Unprotected left main coronary artery bifurcation stenosis: Impact of plaque debulking prior to single sirolimus-eluting stent implantation. J Invasive Cardiol 2008; 20: 505-510.
36. Hu FB, Tamai H, Kosuga K, Kyo E, Hata T, Okada M, et al. Intravascular ultrasound-guided directional coronary atherectomy for unprotected left main coronary stenoses with distal bifurcation involvement. Am J Cardiol 2003; 92: 936-940.
37. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials. Am J Med 2006; 119: 1056-1061.
38. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 667-678.
39. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009; 119: 987-995.
40. Baran KW, Lasala JM, Cox DA, Song A, Deshpande MC, Jacoski MV, et al. A clinical risk score for prediction of stent thrombosis. Am J Cardiol 2008; 102: 541-545.
41. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521.
42. Nakagawa Y, Kimura T, Morimoto T, Nomura M, Saku K, Haruta S, et al. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). Am J Cardiol 2010; 106: 329-336.
43. Alfonso F, Pérez-Vizcayno MJ, Ruiz M, Suárez A, Cazares M, Hernández R, et al. Coronary aneurysms after drug-eluting stent implantation: Clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol 2009; 53: 2053-2060.
44. Ahn CM, Hong BK, Kim JY, Min PK, Yoon YW, Lee BK, et al. Incidence and natural history of coronary artery aneurysm developing after drug-eluting stent implantation. Am Heart J 2010; 160: 987-994.
45. Kim U, Seol SH, Kim DI, Kim DK, Jang JS, Yang TH, et al. Clinical outcomes and the risk factors of coronary artery aneurysms that developed after drug-eluting stent implantation. Circ J 2011; 75: 861-867.
46. Cheng CI, Lee FY, Chang JP, Hsueh SK, Hsieh YK, Fang CY, et al. Long-term outcomes of intervention for unprotected left main coronary artery stenosis: Coronary stenting vs coronary artery bypass grafting. Circ J 2009; 73: 705-712.
47. Hsueh SK, Wu CJ, Fang HY, Hsieh YK, Fang CY, Chen CJ, et al. Comparison of drug-eluting stent with bare metal stent for distal de novo unprotected left main coronary artery stenosis. Circ J 2011; 75: 290-298.
48. Kadota K, Mitsudo K. Percutaneous coronary intervention with drug-eluting stent for unprotected left main trunk disease: Safety and efficacy compared with bare metal stent: Which coronary stent should be used for left main trunk disease? BMS or DES? (DESSide) Circ J 2011; 75: 1250-1254.
49. Kaiser C, Galatius S, Erne P, Eberli F, Alber H, Rickli H, et al. Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med 2010; 363: 2310-2319.